Gestora
RENTA 4 GESTORA, S.G.I.I.C., S.A.
Ver el universo de gestoras de la CNMV →
Ficha de fondo
TRUE VALUE, FI
Categoria
—
Ultimo periodo
1S 2026
Posiciones
36
Cartera notificada con cierre 2026-06-30. Fuente: informe periodico en la CNMV. Ver informe original (PDF)
Cartera completa
Todas las posiciones del ultimo informe periodico, de mayor a menor peso. Los agregados ("resto de renta variable...") son cestas de posiciones pequenas que el propio informe no desglosa linea a linea.
36
Empresa
Tipo
Pais
Peso
Precio
Movimientos del periodo
1S 2026 frente a 2S 2025 (estimada)
Nuevas: 6
Salidas: 3
Incrementos: 13
Recortes: 6
+ NU Holdings Ltd/Cayman Islands
Entra en la cartera con un 1.35% de peso.
Ver ficha de la empresa →− goeasy Ltd
Sale de la cartera; tenia un 5.56% de peso.
− Jackson Financial Inc
Sale de la cartera; tenia un 2.09% de peso.
− Repsol SA
Sale de la cartera; tenia un 1.83% de peso.
▲ Keck Seng Investments
Pasa del 4.63% al 6.58%.
Keck Seng Investments (Hong Kong) Limited, an investment holding company, engages in hotel and club operations, and property investment, development, and management activities in Macau, Vietnam, the People's Republic of China, Japan, Canada, the United States, and Hong Kong. It operates through three segments: Hotel; Property; and Investment and Corporate. The Hotel segment offers hotel room accommodation services; and food and beverages at hotel restaurant outlets, as well as operates slot machines. The Property segment leases investment properties, which primarily consist of retail, commercial, and office properties; and develops, markets, and sells trading properties. Keck Seng Investments (Hong Kong) Limited was incorporated in 1973 and is based in Central, Hong Kong.
Ver ficha de la empresa →▲ Fairfax India Holdings Corp
Pasa del 1.11% al 1.50%.
Fairfax India Holdings Corporation, together with its subsidiaries, operates as an investment holding company in India. It invests in public and private equity securities and debt instruments, as well as Indian businesses or other businesses with customers, suppliers, or business. The company was incorporated in 2014 and is headquartered in Toronto, Canada.
Ver ficha de la empresa →▲ Amrize Ltd
Pasa del 0.97% al 1.19%.
Amrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America and Canada. It operates through two segments, Building Materials and Building Envelope. The Building Materials segment offers cement and aggregates, as well as ready-mix concrete, asphalt, and other construction materials. The Building Envelope segment provides advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coatings; and adhesives, tapes, and sealants. The company was formerly known as Holcim North America Finance Ltd and changed its name to Amrize AG in December 2013. Amrize AG was incorporated in 2023 and is based in Zug, Switzerland.
Ver ficha de la empresa →▼ Teva Pharmaceutical Industries
Pasa del 2.63% al 1.83%.
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, oncology, and other areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE, glatiramer acetate injection to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of tardive dyskinesia, chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder; and ProAir RespiClick inhalation powder. It offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. The company has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. Teva Pharmaceutical Industries Limited was founded in 1901 and is based in Tel Aviv-Yafo, Israel.
Ver ficha de la empresa →Aviso
Esto no es asesoramiento financiero. La cartera procede del informe periodico que el fondo presenta en la CNMV y llega con retraso respecto al cierre real del periodo: es una foto del final de cada semestre, no la cartera en tiempo real.